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Abstract Myosin light chain kinase contains a regulatory
segment consisting of an autoinhibitory region and a calmodu-
lin-binding sequence that folds back on its catalytic core to
inhibit kinase activity. It has been proposed that K-helix
formation may be involved in displacement of the regulatory
segment and activation of the kinase by Ca2/calmodulin.
Proline mutations were introduced at putative non-interacting
residues in the regulatory segment to disrupt helix formation.
Substitution of proline residues immediately N-terminal of the
Trp in the calmodulin-binding sequence had most significant
effects on Ca2/calmodulin binding and activation. Formation of
an K-helix in this region upon Ca2/calmodulin binding may be
necessary for displacement of the regulatory segment allowing
phosphorylation of myosin regulatory light chain.
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1. Introduction
Myosin light chain kinase is a Ca2/calmodulin-dependent
enzyme that catalyzes the phosphorylation of the Ser19 residue
at the N-terminus of the regulatory light chain (RLC) of
myosin II [1,2]. Phosphorylation of the RLC is essential for
smooth muscle contraction [3], potentiation of skeletal and
cardiac muscle contraction [4] and other cellular processes
[5]. Myosin light chain kinase contains a catalytic core homol-
ogous to that of other protein kinases and a regulatory seg-
ment located C-terminal to the catalytic core. The regulatory
segment consists of an autoinhibitory linker region that con-
nects the calmodulin-binding sequence to the catalytic core.
This portion of the kinase appears to fold back onto the
catalytic site to inhibit kinase activity by intrasteric regulation.
Ca2/calmodulin activates myosin light chain kinase presum-
ably due to the speci¢c displacement of the autoinhibitory
region away from the catalytic cleft allowing RLC binding
and phosphorylation.
The calmodulin-binding sequences on a variety of proteins
consist of 16^25 amino acids and share very little homology in
their primary structure, however many have the propensity to
form a basic amphiphilic K-helix [6]. An K-helical wheel rep-
resentation of the calmodulin-binding sequence shows a dis-
tribution of basic and polar residues on one side and hydro-
phobic residues on the opposite side of the helix. In aqueous
solution, synthetic peptides containing calmodulin-binding se-
quences have very little structure. However, the peptides
adopt an K-helical conformation upon binding Ca2/calmod-
ulin or if the polarity of the solvent is decreased.
The structures of Ca2/calmodulin complexed with peptides
containing the calmodulin-binding sequences from smooth
and skeletal muscle myosin light chain kinase were determined
by small-angle X-ray and neutron scattering [7], high-resolu-
tion NMR [8], and X-ray crystallography [9]. Ca2/calmodu-
lin undergoes a conformational collapse with its two lobes
wrapping around the peptide through the bending of the £ex-
ible central helix. The central helix unwinds bringing the two
lobes closer to each other in a cis orientation. The collapse of
the calmodulin structure around the target is accompanied by
the peptide adopting a single K-helix in an antiparallel orien-
tation. Trp4 and Phe17 of the myosin light chain kinase pep-
tide bind to the hydrophobic patches in the C- and N-terminal
domains of calmodulin. However, small-angle scattering stud-
ies demonstrate that the binding of calmodulin to isolated
peptide employs di¡erent determinants compared to calmod-
ulin binding to the same sequence within the enzyme [10].
Prolines are known to destabilize an K-helix by introducing
a kink in the helix [11], and are the least common residues
within K-helices of crystallized proteins [12]. Substitution of
proline residues at strategic positions in the autoinhibitory
linker region and the calmodulin-binding sequence in myosin
light chain kinase reveal the importance of K-helical structures
in both autoinhibition and Ca2/calmodulin-binding activa-
tion.
2. Materials and methods
2.1. Oligonucleotide-directed mutagenesis
A 1300 base pair 5P BamHI-XbaI-3P cDNA fragment, coding for the
C-terminal half of rabbit smooth muscle myosin light chain kinase
without the telokin Ig-like motif (amino acids 587^1003) was sub-
cloned into M13mp18 vector and was used to make single-stranded
DNA template for oligonucleotide-directed mutagenesis. To produce
the M968P, A983P, and A986P mutants (Fig. 1) with desired substi-
tutions at particular amino acid residues, oligonucleotides (M968P, 5P-
GTACTTCTTCGGGCGGTCCTTGG-3P ; A983P, 5P-GCTCTCA-
CAGGATTGCCCGT-3P ; and A986P, 5P-GTCTTCCAATGGGTCT-
CACAGC-3P) were designed as the non-coding strand of smooth
muscle myosin light chain kinase. The oligonucleotides were
phosphorylated by 0.4 units/Wl T4 polynucleotide kinase (Life Tech-
nologies, Inc.) at 37‡C for 30 min followed by heat inactivation at
70‡C for 15 min prior to use in mutagenesis. Oligonucleotide-directed
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mutagenesis was performed using Sculptor mutagenesis kit (Amer-
sham Pharmacia Biotech). DNA sequencing was performed to verify
the desired nucleotide substitutions for each mutant cDNA [13]. The
mutated regions were subcloned into pat21/pCMV5B containing the
nucleotide sequence for the C-terminal half of the kinase.
2.2. Expression of wild-type and mutant smooth muscle myosin light
chain kinases
COS-7 African green monkey kidney cells (obtained from ATCC,
CRL-1651) were maintained in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) containing 4 mM L-glutamine, 1.5 g/l sodium bicarbonate,
4.5 g/l glucose, 1 mM sodium pyruvate, 10% fetal bovine serum, 100
units/ml penicillin, and 100 ug/ml streptomycin at 37‡C with 5% CO2.
The myosin light chain kinase proline mutants in pCMV5 expression
vector were transfected into COS-7 cells using Fugene1-6 transfection
reagent (Roche Molecular Biochemicals) as described by the manu-
facturer. The cells were collected and lysed on ice in a bu¡er (lysis
bu¡er) containing 20 mM MOPS at pH 7.5, 1% Nonidet P-40, 0.5
mM EGTA, 50 mM magnesium chloride, 10% glycerol, 10 mM di-
thiothreitol, 10 Wg/ml leupeptin, 10 Wg/ml pepstatin, 10 Wg/ml soybean
trypsin inhibitor, 20 Wg/ml aprotinin, 0.25 mM benzamidine, 120 Wg/
ml NK-p-tosyl-L-lysine chloromethyl ketone, and 100 Wg/ml phenyl-
methylsulfonyl £uoride. The lysates were centrifuged at 7000Ug for
2 min at 4‡C to remove the insoluble fraction. Aliquots of the COS-7
cell lysates were frozen in liquid nitrogen and stored at 380‡C. The
quantity of the kinases in COS-7 cell lysates was determined by im-
munoblotting with various amounts of rabbit smooth muscle myosin
light chain kinase puri¢ed from Sf9 cells [14] as standard and probing
with anti-myosin light chain kinase monoclonal antibody which rec-
ognizes the N-terminus of the kinase.
2.3. Myosin light chain kinase assays
To determine the Ca2/calmodulin-dependent activity of wild-type
and mutant smooth muscle myosin light chain kinases, 32P incorpo-
ration into myosin RLC was measured [15]. Myosin RLC was puri¢ed
from turkey gizzards [16]. Calmodulin was puri¢ed from bovine testes
[17] and from Escherichia coli SMH 174 (DE3) expressing bovine
calmodulin [18] as previously described. Maximal kinase activity
was determined in reactions having 50 mM MOPS at pH 7.0,
10 mM magnesium acetate, 1 mM dithiothreitol, 0.3 mM CaCl2,
1 mM [Q-32P]ATP (200^300 cpm/pmol, purchased from ICN), 1 WM
calmodulin, 26.5 WM RLC, and diluted lysates of myosin light chain
kinase. Lysates were freshly diluted in 25 mM MOPS at pH 7.0, 5 mM
magnesium acetate, and 1 mM dithiotreitol and added to reaction
mixtures. Final concentrations of myosin light chain kinase used
showed linear phosphorylation rates with respect to time and enzyme
concentration. Km and Vmax values were obtained from Lineweaver-
Burke plots after measuring the rates of 32P incorporation under
varying myosin RLC concentrations. Ca2/calmodulin-independent
activity of the lysates was measured in the presence of 4 mM
EGTA in the absence of exogenous Ca2 and calmodulin. Mock
transfected lysates diluted 1:10 exhibited 6 5% of the total kinase
activity, with no detectable activity observed in the presence of
4 mM EGTA.
Calmodulin activation properties of mutant smooth muscle myosin
light chain kinase in COS-7 cell lysates were examined by performing
Ca2 activation assays as previously described [19]. To assess the rel-
ative KCaM values of mutant kinases in COS-7 cell lysates, the kinase
activities were measured at 1 WM CaM with varying free Ca2 con-
centrations from 200 nM to 100 WM with a Ca2/EGTA bu¡er system
[20]. The added calmodulin was in great excess of the endogenous
calmodulin contributed by the COS-7 cell lysate which provides con-
trolled conditions to determine the relative concentrations of Ca2/
calmodulin required for kinase activation. Therefore, the free Ca2
concentration determines the concentration of Ca2/calmodulin. To
establish the quantitative changes in the calmodulin activation proper-
ties (KCaM) of mutant myosin light chain kinases, the ratio of activities
at Ca2 concentrations that resulted in less than maximal activity to
the maximal activity measured at 100 WM Ca2 was determined as
previously described [21^23]. The ratio of activity at a speci¢c Ca2
concentration that is less than required for maximal activity decreases
as the KCaM value for a mutant myosin light chain kinase increases
relative to the wild-type enzyme. In the same manner, if the ratio of
activity increases, the KCaM value decreases. In this analysis, it is
assumed that the Ca2-binding properties of calmodulin are not
changed and that a single Ca2 complex is needed to activate the
kinase. The ratio of activities is used to calculate the fold di¡erence
in KCaM relative to wild-type smooth muscle myosin light chain kinase
with an average KCaM value of 1 nM [1,21^23].
2.4. Immunoprecipitation of wild-type and mutant smooth muscle
myosin light chain kinase
COS-7 cell lysates were diluted in lysis bu¡er containing 1 WM
calmodulin, 1 mg/ml bovine serum albumin, 0.5 mM EGTA or 10
mM Ca2. The diluted lysates were incubated with polyclonal anti-
bodies raised against the full-length kinase followed by the addition of
protein A-Sepharose (Amersham Pharmacia Biotech). The amount of
polyclonal antibody used was su⁄cient to precipitate all of the proline
myosin light chain kinase mutant as determined by titrating increasing
quantities of the antibody with a ¢xed amount of the target protein.
The immune complexes were collected by centrifugation, washed with
lysis bu¡er, boiled in 5ULaemmli sample bu¡er containing 0.5 mM
EGTA, and then subjected to SDS^PAGE. Immunoprecipitates were
analyzed by Western blotting using anti-myosin light chain kinase and
anti-calmodulin monoclonal antibodies (Upstate Biotechnology, Inc.).
3. Results
3.1. Kinetic properties of smooth muscle myosin light chain
kinase proline mutants
Residues Met968, Ala983, or Ala986 in the regulatory segment
of smooth muscle myosin light chain kinase show no evidence
of direct interaction with the catalytic core or calmodulin thus
mutagenesis of these residues should not a¡ect autoinhibition
and Ca2/calmodulin activation of the kinase by altering the
conformation of the regulatory segment. In addition, the Gar-
nier-Osguthorpe-Robson (GOR) secondary structure predic-
tion method version IV [24] predicts the K-helix as the pre-
dominant secondary structure in the regulatory segment of
myosin light chain kinase and that individual substitution of
residues Met968, Ala983, or Ala986 to proline (Fig. 1) would
disrupt the putative K-helical structure at the N- or C-terminal
of the regulatory segment (Fig. 2). Thus, proline substitution
mutations of these residues were performed to disrupt K-hel-
ical formation. The proline substitution of residue Met968
within the autoinhibitory linker region showed a modest
change in [Ca2]0:5 with a KCaM value of 0.4 nM compared
to 1 nM for wild-type kinase (Table 1). In addition, Ca2/
calmodulin-independent kinase activity (10% of total activity)
Fig. 1. Proline substitution mutants of rabbit smooth muscle myosin
light chain kinase. The regulatory segment of smooth muscle myosin
light chain kinase contains the calmodulin-binding sequence (Ala973
to Ser992) and the linker region, which connects the catalytic core to
the calmodulin-binding sequence. Underlined residues are those ami-
no acids that contribute to autoinhibition [35^38]. The asterisks
identify residues essential for high-a⁄nity calmodulin binding [39].
The proline substitutions at Met968, Ala983, and Ala986 are shown
below the sequence of the regulatory segment.
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was observed with the M968P mutant (data not shown). The
mutant A983P in the calmodulin-binding sequence resulted in
a dramatic increase in the Ca2 required for half-maximal
activation (E10 WM) with greater than a 20-fold increase
in the KCaM values. The A986P mutant required signi¢cantly
more Ca2 for half-maximal activation (3.8 WM) with only a
5-fold increase in the KCaM value relative to wild-type kinase.
There were modest changes in the Km and Vmax values of the
M968P mutant. The Km value for light chain could not be
measured for the A983P mutant; the speci¢c activity of the
kinase was 2.4 vs. 18 Wmol 32P/min/mg for the wild-type ki-
nase (Table 1).
3.2. Calmodulin-binding properties of proline mutants of
smooth muscle myosin light chain kinase
The ability of calmodulin to induce helicity in the target
sequence may be required for calmodulin binding. To show
binding of calmodulin to the proline mutants, immunopreci-
pitation was performed using anti-myosin light chain kinase
monoclonal antibody. COS-7 cell lysates expressing wild-type
and mutant kinases were subjected to immunoprecipitation
with an anti-myosin light chain kinase monoclonal antibody
in the presence of Ca2 or EGTA. Both wild-type and mutant
kinases were immunoprecipitated (Fig. 3A). In the presence of
Ca2, calmodulin co-immunoprecipitated with wild-type,
M968P, and A986P mutant kinases. However, calmodulin
was not present in immunoprecipitates of A983P mutant ki-
nase. Calmodulin did not co-immunoprecipitate with either
the wild-type or mutant kinases in the presence of EGTA
(Fig. 3B).
4. Discussion
Alanine scanning mutagenesis within the calmodulin-bind-
ing sequence of smooth muscle myosin light chain kinase re-
vealed that calmodulin binding by the enzyme is determined
by an interplay of speci¢c hydrophobic and electrostatic in-
teractions [25]. Accordingly, we selected neutral alanine resi-
dues within the calmodulin-binding sequence and substituted
them with proline residues that would disrupt helix formation.
The proline substitution mutants A983P and A986P in the
calmodulin-binding sequence were less easily activated by
Ca2/calmodulin (increased [Ca2]0:5 and KCaM values relative
to wild-type) most likely due to the disruption of helix for-
mation induced by calmodulin binding.
Mutagenesis of residue Ala983 not only resulted in a dra-
matic increase in the KCaM value but also inhibited high-a⁄n-
Fig. 2. Secondary structure predictions in the rabbit smooth muscle
myosin light chain kinase regulatory segment. The Garnier-Osgu-
thorpe-Robson (GOR) secondary structure prediction method ver-
sion IV [24] was used to determine the K-helical content of residues
948^1005 for wild-type and mutant M968P, A983P, and A986P ki-
nases. The amino acid sequence of the wild-type kinase residues
948^1005 is given at the bottom with the corresponding secondary
structure prediction (H, helix; C, coil) and the sites of proline muta-
tions are underlined.
Table 1
Kinetic properties of myosin light chain kinase containing proline mutations within the regulatory segment
Kinase [Ca2]0:5 (WM) KCaM (nM) KmLC (WM) Vmax (Wmol32P/min/mg)
Wild-type 0.6 þ 0.03 1.0 14 þ 1.4 15 þ 0.9
M968P 0.3 þ 0.02 0.4 þ 0.03 6.7 þ 0.5 7.9 þ 0.5
A983P E10 E20 n.d. (2.4 þ 0.3)
A986P 3.8 þ 0.69 5.1 þ 0.26 11 þ 0.8 15 þ 0.6
Mutagenesis, expression in COS-7 cells, quantitation of expressed kinase in COS-7 cell extracts, and measurement of kinetic properties of rabbit
smooth muscle myosin light chain kinases were performed as described in Section 2. Values are means þ standard errors for at least three ex-
periments with lysates from transfections representing at least two independent mutations. [Ca2]0:5 values represent the Ca2 concentration re-
quired for half-maximal activation at 1 WM calmodulin. The relative KCaM values were calculated for at least three Ca2 concentrations. Vmax
and Km values were determined from Lineweaver-Burke plots. KmLC refers to Km values for the RLC; n.d., values not determined. Speci¢c ac-
tivity value of A983P enclosed in parentheses vs. 18 þ 0.8 Wmol 32P/min/mg for wild-type kinase.
Fig. 3. Binding of calmodulin to myosin light chain kinases contain-
ing proline mutations of residues within the regulatory segment.
COS-7 cell lysates expressing wild-type and mutant kinases were im-
munoprecipitated with anti-myosin light chain kinase (K-MLCK)
antibody in the presence of calmodulin and Ca2 or EGTA. Immu-
noprecipitates were analyzed by Western blotting using anti-myosin
light chain kinase (K-MLCK; panel A) and anti-calmodulin (K-
CaM; panel B) antibodies following SDS^PAGE. Lane 1, wild-
type; lane 2, M968P; lane 3, A983P; lane 4, A986P; lane C, puri-
¢ed kinase or calmodulin control.
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ity Ca2/calmodulin binding to the kinase. The results with
Ala983 were most interesting since this residue is close to the
tryptophan residue at the N-terminus of the calmodulin-bind-
ing sequence that has been shown by Bayley and coworkers
[26] to be important for binding to the calmodulin C domain,
which then induces a high degree of helicity in a model pep-
tide. The ability to induce helicity in the target sequence may
be connected with the ability to activate the enzyme. The C
domain of calmodulin is generally more e¡ective than the N
domain in maintaining helicity of the peptide; likewise, the
separated C domain of calmodulin activates myosin light
chain kinase to 65%, whereas the N domain hardly activates
the enzyme. Based on the relative e¡ects of proline mutations
in Ala983 and Ala986, the region immediately C-terminal of the
tryptophan in the calmodulin-binding sequence may be most
important in forming an K-helix with the C domain of cal-
modulin leading to activation.
The two-dimensional NMR structure of the autoinhibitory
linker region and part of the calmodulin-binding sequence of
smooth muscle myosin light chain kinase shows that an amino
acid corresponding to Met968 is located at the start of an K-
helical segment extending to the Trp residue in the calmodu-
lin-binding sequence [27]. In addition, the crystal structures of
Ca2/calmodulin-dependent protein kinase I, twitchin kinase
and titin kinase demonstrate that the region in their regula-
tory segments equivalent to the linker region in myosin light
chain kinase also forms an K-helix [28^31]. Furthermore, re-
sults obtained upon substitution of Cys289 to a proline in the
linker sequence preceding the calmodulin-binding sequence in
Ca2/calmodulin-dependent protein kinase II suggests the
presence of an K-helical structure important for Ca2/calmod-
ulin activation [32]. Amino acid Met968 in the linker region of
myosin light chain kinase corresponds to Cys289 in Ca2/cal-
modulin-dependent protein kinase II. Mutagenesis of residue
Met968 made the kinase more easily activated by Ca2/cal-
modulin, however the magnitude of the e¡ect was small. In
addition, there was enhanced Ca2/calmodulin-independent
kinase activity (10% of total activity) while maximal activity
was decreased. We conclude that secondary structure within
the linker sequence may be important for the proper orienta-
tion of residues within the autoinhibitory linker region to
interact with the catalytic core.
Alternatively, proline in a polypeptide chain has less con-
formational freedom than other amino acids, as the pyrroli-
dine ring of proline imposes rigid constraints on the N^CK
rotation and restricts the available conformational space of
the preceding residue of proline [33]. In regions devoid of K-
helical structures proline may not function as a helix breaker
but may provide molecular rigidity at turns or in random
regions by tightening the surrounding conformation as a re-
sult of reducing the backbone £exibility [34]. However based
on the following observations that (1) K-helical segments are
present in synthetic peptide containing the autoinhibitory
linker region of myosin light chain kinase; (2) an increase in
the helicity of the calmodulin-binding sequence of myosin
light chain kinase is accompanied by the collapse of calmod-
ulin about its target peptide; and (3) calmodulin forms a
collapsed structure about the intact kinase, it is most likely
that introducing an K-helix breaker within the linker region
and the calmodulin-binding sequence of myosin light chain
kinase disrupts autoinhibition and prevents the collapse of
calmodulin about its target sequence resulting in the lost of
high-a⁄nity binding of calmodulin to the kinase.
In summary, substitutions of proline residues at strategic
positions reveal that the region C-terminal of the tryptophan
in the N-terminus calmodulin-binding sequence is important
in calmodulin binding and activation. The ability of calmod-
ulin to induce helicity in its binding sequence when it forms a
collapsed structure may be connected to its ability to activate
myosin light chain kinase. Finally, the presence of an K-helical
structure within the linker sequence may help to orient resi-
dues to interact with the catalytic core during intrasteric reg-
ulation of the kinase.
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